Anthony Davis

Tony Davis is the President, a Managing Partner and Co-Founder of Linden Capital Partners. He has been involved in principal investing and consulting since 1992. Prior to co-founding Linden Capital Partners, Mr. Davis was a Partner with One Equity Partners (formerly FCEC) and a strategy and operations management consultant with Cresap, McCormick and Paget in Chicago and Hong Kong.  He currently serves on the boards of ProPharma, Smile Doctors and Spear Education and is Chairman of the boards of Advarra, Sage Dental and Virtus Pharmaceuticals. He previously served on the boards of directors for Behavioral Centers of America, Drayer Physical Therapy Institute, Focused Health Solutions, Ranir and Young Innovations. Additionally, Mr. Davis is a member of the Chicago Commonwealth Club, The Chicago Council on Global Affairs, The Commercial Club of Chicago, The Economic Club of Chicago and is a Director on the Northwestern Memorial Foundation Board of Directors and a member of the Northwestern Memorial Foundation Executive Committee. Tony is also on the University of Chicago Booth School of Business Polsky Center Private Equity Council.

Mr. Davis holds a Bachelor of Arts with honors in Economics from Northwestern University and an MBA with honors from the University of Chicago Booth School of Business, where he was a Rosett Scholar and serves as a guest lecturer on private equity.

Company Blog

May 14, 2018
The Power to See Differences that Matter
What are the real-world consequences of giving inadequate consideration to power when developing a… Read More
April 24, 2018
ProPharma Group Announces New President / CEO
ProPharma Group announces today that Dawn Sherman will be joining the company as President… Read More
April 3, 2018
Understanding the New Combination Product PMSR Guidance Documents and Impact…
Take a closer look at new FDA guidance documents surrounding postmarketing safety reporting (PMSR)… Read More
More Articles

UPCOMING Events

June 04, 2018
BIO International
The BIO International Convention  attracts more than 16,000 biotechnology and pharma leaders who come togethe... Read More
June 05, 2018
DIA Pharmacovigilance Conference
Join the DIA Pharmacovigilance Conference to discuss the current landscape and join intense and well-lead dis... Read More
June 24, 2018
DIA Annual 2018
The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to ... Read More
All Events
Contact Us